Cas no 182760-06-1 (Ravuconazole)
Ravuconazole is a triazole antifungal agent with broad-spectrum activity against pathogenic fungi, including Candida, Aspergillus, and Cryptococcus species. Its mechanism of action involves inhibition of fungal cytochrome P450-dependent 14α-demethylase, disrupting ergosterol biosynthesis and compromising cell membrane integrity. Ravuconazole exhibits favorable pharmacokinetic properties, such as prolonged half-life and high tissue penetration, enabling less frequent dosing compared to other azoles. It demonstrates potent in vitro and in vivo efficacy, particularly against azole-resistant strains, due to its strong binding affinity to the target enzyme. The compound's stability and low toxicity profile make it a promising candidate for systemic antifungal therapy, including invasive infections. Clinical studies highlight its potential for both oral and intravenous administration.
Ravuconazole structure
Product Name:Ravuconazole
CAS No:182760-06-1
MF:C22H17F2N5OS
MW:437.465089559555
MDL:MFCD00941002
CID:834550
PubChem ID:467825
Update Time:2025-06-09
Ravuconazole Chemical and Physical Properties
Names and Identifiers
-
- 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)b utan-2-yl]-1,3-thiazol-4-yl]benzonitrile
- Ravuconazole
- RAVUCONAZOLE,OFF-WHITE SOLID
- BMS 207147
- ER 30346
- RCZ
- 4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
- BMS-207147
- ER-30346
- Aids057176
- Aids-057176
- Ravuconazole, BMS-207147
- Benzonitrile, 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-
- Bms-207,147
- BMS-207147/Ravuconazole
- 95YH599JWV
- BMS-20714
- NS00066831
- p-(2-((alphaR,betaR)-2,4-Difluoro-beta-hydroxy-alpha-methyl-beta-(1H-1,2,4-triazol-1-ylmethyl)phenethyl)-4-thiazolyl)benzonitrile
- BRD-K03503561-001-01-4
- Benzonitrile, 4-[2-[(1R,2R)-2-(2,4-difluro-phenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-
- DB06440
- UNII-95YH599JWV
- RAVUCONAZOLE [WHO-DD]
- ravuconazol
- BDBM50011476
- Benzonitrile, 4-(2-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)-
- CHEBI:143825
- Q7296826
- BMS 207147;ER 30346;BMS207147;ER30346;BMS-207147;ER-30346
- ravuconazolum
- HY-14272
- (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-butan-2-ol
- (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
- Benzonitrile, 4-[2-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, [R-(R*,R*)]-
- (1R,2R)-4-[2-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]thiazol-4-yl]benzonitrile
- Ravuconazole [INN]
- 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1,2,4-triazol-1-yl)propyl]thiazol-4-yl]benzonitrile
- AKOS015962202
- D02556
- RAVUCONAZOLE [MART.]
- 4-(2-((2R,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile
- CHEMBL294029
- OPAHEYNNJWPQPX-RCDICMHDSA-N
- BMS-207147;ER-30346
- EX-A3369
- 3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
- RAVUCONAZOLE [MI]
- 182760-06-1
- MFCD00941002
- 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile
- Ravuconazole (prop.INN)
- 194798-96-4
- MS-27838
- BCP9000424
- 4-(2-((2R,3R)-Rel-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile
- SCHEMBL939026
- BCP05803
- CS-6927
-
- MDL: MFCD00941002
- Inchi: 1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1
- InChI Key: OPAHEYNNJWPQPX-RCDICMHDSA-N
- SMILES: S1C=C(C2C=CC(C#N)=CC=2)N=C1[C@H](C)[C@@](C1C=CC(=CC=1F)F)(CN1C=NC=N1)O
Computed Properties
- Exact Mass: 437.11200
- Monoisotopic Mass: 437.112187
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 31
- Rotatable Bond Count: 6
- Complexity: 657
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: 3.5
- Topological Polar Surface Area: 116
Experimental Properties
- Density: 1.38±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: 64-66°C
- Boiling Point: 674.9°C at 760 mmHg
- Flash Point: 362°C
- Refractive Index: 1.665
- Solubility: Insuluble (9.6E-4 g/L) (25 oC),
- PSA: 115.86000
- LogP: 4.24298
- Specific Rotation: D24 -29.1° (c = 1.03 in methanol)
- Optical Activity: [α]/D -27 to -33°, c =?1 in methanol
Ravuconazole Security Information
- Hazardous Material transportation number:NONH for all modes of transport
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Ravuconazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-2 mg |
Ravuconazole |
182760-06-1 | 2mg |
¥462.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-5 mg |
Ravuconazole |
182760-06-1 | 5mg |
¥687.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-10 mg |
Ravuconazole |
182760-06-1 | 10mg |
¥1227.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-25 mg |
Ravuconazole |
182760-06-1 | 25mg |
¥2627.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-50 mg |
Ravuconazole |
182760-06-1 | 50mg |
¥4737.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-100 mg |
Ravuconazole |
182760-06-1 | 100MG |
¥7127.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T7152-1 mL * 10 mM (in DMSO) |
Ravuconazole |
182760-06-1 | 1 mL * 10 mM (in DMSO) |
¥777.00 | 2022-04-26 | ||
| ChemScence | CS-6927-2mg |
Ravuconazole |
182760-06-1 | 99.88% | 2mg |
$60.0 | 2022-04-27 | |
| ChemScence | CS-6927-5mg |
Ravuconazole |
182760-06-1 | 99.88% | 5mg |
$96.0 | 2022-04-27 | |
| ChemScence | CS-6927-10mg |
Ravuconazole |
182760-06-1 | 99.88% | 10mg |
$168.0 | 2022-04-27 |
Ravuconazole Suppliers
Amadis Chemical Company Limited
Gold Member
(CAS:182760-06-1)Ravuconazole
Order Number:A855884
Stock Status:in Stock
Quantity:1g/5g
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 07:57
Price ($):195.0/647.0
Email:[email protected]
Ravuconazole Related Literature
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
-
Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
-
3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
-
Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
-
M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
182760-06-1 (Ravuconazole) Related Products
- 241479-67-4(Isavuconazole)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
Recommended suppliers
Amadis Chemical Company Limited
(CAS:182760-06-1)Ravuconazole
Purity:99%/99%
Quantity:1g/5g
Price ($):195.0/647.0